Core Viewpoint - As of July 30, 2025, Lino Pharmaceutical Packaging Co., Ltd. (力诺药包) reported a stock price of 21.07 yuan, reflecting a decline of 1.86% with a trading volume of 78,400 hands and a transaction amount of 168 million yuan [1] Financial Performance - The latest quarterly report for Lino Pharmaceutical shows total operating revenue of 276 million yuan, representing a year-on-year growth of 3.38% [1] - The net profit attributable to shareholders reached 40.52 million yuan, marking a significant year-on-year increase of 63.36% [1] - The non-recurring net profit was 37.08 million yuan, with a year-on-year growth of 67.51% [1] - The company's liquidity ratios are strong, with a current ratio of 3.864 and a quick ratio of 3.072, while the debt-to-asset ratio stands at 35.45% [1] Company Overview - Lino Pharmaceutical Packaging Co., Ltd. was established in 2002 and is located in Jinan City, primarily engaged in the non-metallic mineral products industry [2] - The company has a registered capital of 2.324 billion yuan and a paid-in capital of 1.5168 billion yuan [1] - The legal representative of the company is Yang Zhongchen [1] Investment and Intellectual Property - The company has made investments in 7 enterprises and participated in 109 bidding projects [2] - Lino Pharmaceutical holds 22 trademark registrations and 163 patents, along with 53 administrative licenses [2]
力诺药包(301188)7月30日主力资金净流出1046.77万元